INNOVATE BIOPHARMA CONSULTING LIMITED is an active Private Limited Company, registered at Companies House under the number 12608089. INNOVATE BIOPHARMA CONSULTING LIMITED was incorporated on 18 May 2020 with a registered office address based in Farnham. INNOVATE BIOPHARMA CONSULTING LIMITED has been operating for 5 year(s) and 0 month(s). According to the latest confirmation statement submitted on 7 May 2025, there is currently 3 active director(s) and activities related to the SIC Code 72110 - Research and experimental development on biotechnology.
BUY A REPORT
Our reports include up to 40+ pages of legal structure data, accounts filings and
sectorial
analysis, in a PDF format you can download on all your devices.
View an Example
Active since incorporation
Last submitted on 7 May 2025 (1 months ago)
Next confirmation dated 7 May 2026
Due by 21 May 2026 (12 months remaining)
1 change of name occurred since incorporation
Last accounts submitted for period 31 October 2023 (19 months ago)
Accounts type was Dormant
Next accounts dated 31 October 2024
Due by 31 July 2025
Private Limited Company with Share Capital
Incorporated 5 year(s) and 0 month(s) ago
72110 - Research and experimental development on biotechnology
48A Farnborough Road
Farnham
GU9 9AH
United Kingdom
To access some of these services, you will need the Companies House issued authentication code. We can send your authentication code to the company’s registered address.
Our reports include up to 40+ pages of legal structure data, accounts filings and
sectorial
analysis, in a PDF format you can download on all your devices.
View an Example
This information is private and is only available in our reports....
BUY A REPORT
Our reports include up to 40+ pages of legal structure data, accounts filings and
sectorial
analysis, in a PDF format you can download on all your devices.
View an Example
Our reports include up to 40+ pages of legal structure data, accounts filings and
sectorial
analysis, in a PDF format you can download on all your devices.
View an Example